Skip to content
Life Sciences Seed Founded 2020

Nanite

Developer of AI-driven non-viral gene delivery systems

📍 Boston, United States · Drug Delivery

Funding snapshot

Last roundSeed
Amount$2M
Date8 May 2024

About

Developer of AI-driven non-viral gene delivery systems. It uses artificial intelligence to design and synthesize polymer nanoparticles for targeted and safe gene therapy. These nanoparticles offer advantages over traditional viral vectors and lipid nanoparticles, addressing a major hurdle in gene therapy. The platform combines high-throughput synthesis, biology, materials science, and artificial intelligence to create programmable and effective delivery vehicles for a wide range of genetic medicines.

Latest news

No articles yet.

Raising like Nanite?

Analyze your pitch deck before your next raise.

Analyze My Deck →